Back to User profile » Prof. Dr. Salvatore Accomando
Paper published by Prof. Dr. Salvatore Accomando:
Original Research
Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
Alvisi P, Arrigo S, Cucchiara S, Lionetti P, Miele E, Romano C, Ravelli A, Knafelz D, Martelossi S, Guariso G, Accomando S, Zuin G, De Giacomo C, Balzani L, Gennari M, Aloi M
Biologics: Targets and Therapy 2019, 13:13-21
Published Date: 3 January 2019